Comparative Pharmacology
Head-to-head clinical analysis: CEPHULAC versus MAGNESIUM SULFATE ANHYDROUS POTASSIUM SULFATE SODIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CEPHULAC versus MAGNESIUM SULFATE ANHYDROUS POTASSIUM SULFATE SODIUM SULFATE.
CEPHULAC vs MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose, a synthetic disaccharide, is not absorbed from the gastrointestinal tract. It is metabolized by colonic bacteria to form short-chain fatty acids (e.g., lactic, acetic, formic acids), which acidify the colonic contents. In hepatic encephalopathy, the acidic environment converts ammonia (NH3) to ammonium (NH4+), which is poorly absorbed and excreted in feces. Additionally, the osmotic effect of lactulose draws water into the colon, softening stools and increasing bowel movements.
Osmotic laxative that retains water in the bowel lumen via osmotic gradient, inducing diarrhea to cleanse the colon. Sodium sulfate, potassium sulfate, and magnesium sulfate are poorly absorbed, creating an osmotic effect. Additionally, magnesium may stimulate cholecystokinin release.
30-45 mL (6.67-10 g lactulose) orally 3-4 times daily for constipation; for hepatic encephalopathy, 30-45 mL orally 3-4 times daily titrated to produce 2-3 soft stools per day, or 300 mL in 700 mL of water or saline as retention enema for 30-60 min every 4-6 hours.
For bowel cleansing prior to colonoscopy: 3 packets (each packet contains 1.6 g magnesium sulfate anhydrous, 3.13 g potassium sulfate, and 1.5 g sodium sulfate) dissolved in water to make 16 ounces, followed by additional water: administer as a split-dose regimen (one 16-ounce solution the evening before and one 16-ounce solution on the day of the procedure).
None Documented
None Documented
Terminal elimination half-life is 7-10 hours (renal impairment: prolonged); systemic absorption is minimal (<3%) after oral administration, so half-life reflects clearance of absorbed fraction.
Not applicable as a systemic half-life; the drug acts locally in the gastrointestinal tract. For absorbed sulfate, elimination half-life is approximately 6-8 hours in patients with normal renal function.
Primarily renal (20-30% as unchanged drug) and fecal (up to 70% as unmetabolized drug via biliary elimination; following gastric acid-mediated degradation, only 5-10% reaches urine as intact lactulose; hepatic metabolism is negligible).
Primarily renal excretion. Approximately 20% of sulfate is absorbed and excreted in urine; the remainder is eliminated fecally as unabsorbed drug. Potassium is mostly reabsorbed; excess is excreted renally.
Category C
Category C
Laxative
Laxative